State Of Tennessee, Treasury Department Zymeworks Inc. Transaction History

State Of Tennessee, Treasury Department

  • $27.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$24.28 - $49.8 $68,663 - $140,834
-2,828 Closed
0 $0
Q3 2019

Oct 30, 2019
SELL
$22.78 - $29.08 $89,183 - $113,848
-3,915 Reduced 58.06%
2,828 $70,000
Q2 2019

Aug 12, 2019
BUY
$15.0 - $22.49 $74,805 - $112,157
4,987 Added 284.0%
6,743 $148,000
Q3 2018

Nov 13, 2018
BUY
$12.21 - $16.61 $21,440 - $29,167
1,756 New
1,756 $28,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $917M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email